Found: 22
Select item for more details and to access through your institution.
Phase 1b Trial of Biweekly Intravenous Pexa-Vec (JX-594), an Oncolytic and Immunotherapeutic Vaccinia Virus in Colorectal Cancer.
- Published in:
- Molecular Therapy, 2015, v. 23, n. 9, p. 1532, doi. 10.1038/mt.2015.109
- By:
- Publication type:
- Article
Phase 1 Study of Intratumoral Pexa-Vec (JX-594), an Oncolytic and Immunotherapeutic Vaccinia Virus, in Pediatric Cancer Patients.
- Published in:
- Molecular Therapy, 2015, v. 23, n. 3, p. 602, doi. 10.1038/mt.2014.243
- By:
- Publication type:
- Article
First-in-man Study of Western Reserve Strain Oncolytic Vaccinia Virus: Safety, Systemic Spread, and Antitumor Activity.
- Published in:
- Molecular Therapy, 2015, v. 23, n. 1, p. 202, doi. 10.1038/mt.2014.194
- By:
- Publication type:
- Article
Use of combined treatment of 3rd-generation cephalosporin, azithromycin and antiviral agents on moderate SARs-CoV-2 patients in South Korea: A retrospective cohort study.
- Published in:
- PLoS ONE, 2022, v. 17, n. 5, p. 1, doi. 10.1371/journal.pone.0267645
- By:
- Publication type:
- Article
A Fully Integrated Sensor SoC with Digital Calibration Hardware and Wireless Transceiver at 2.4 GHz.
- Published in:
- Sensors (14248220), 2013, v. 13, n. 5, p. 6775, doi. 10.3390/s130506775
- By:
- Publication type:
- Article
Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans.
- Published in:
- Nature, 2011, v. 477, n. 7362, p. 99, doi. 10.1038/nature10358
- By:
- Publication type:
- Article
Preclinical safety evaluation of hepatic arterial infusion of oncolytic poxvirus.
- Published in:
- Drug Design, Development & Therapy, 2018, v. 12, p. 2467, doi. 10.2147/DDDT.S171269
- By:
- Publication type:
- Article
The Oncolytic Poxvirus JX-594 Selectively Replicates in and Destroys Cancer Cells Driven by Genetic Pathways Commonly Activated in Cancers.
- Published in:
- Molecular Therapy, 2012, v. 20, n. 4, p. 749, doi. 10.1038/mt.2011.276
- By:
- Publication type:
- Article
A Mechanistic Proof-of-concept Clinical Trial With JX-594, a Targeted Multi-mechanistic Oncolytic Poxvirus, in Patients With Metastatic Melanoma.
- Published in:
- Molecular Therapy, 2011, v. 19, n. 10, p. 1913, doi. 10.1038/mt.2011.132
- By:
- Publication type:
- Article
Sequential Therapy With JX-594, A Targeted Oncolytic Poxvirus, Followed by Sorafenib in Hepatocellular Carcinoma: Preclinical and Clinical Demonstration of Combination Efficacy.
- Published in:
- Molecular Therapy, 2011, v. 19, n. 6, p. 1170, doi. 10.1038/mt.2011.39
- By:
- Publication type:
- Article
167. Both Oncolysis and Tumor Immunity Are Involved in an Autitumoral Efficacy by Intratumoral Injection of Recombinant Vaccinia Virus (TK Deleted, hGM-CSF Inserted Wyeth Strain) in a VX2 Rabbit Model
- Published in:
- 2005
- By:
- Publication type:
- Abstract
168. Antitumoral Efficacy of Multiple Injection of JX-594 (Thymidine Kinase (TK) Deleted, Human GM-CSF Inserted Wyeth Strain) Via Tail Vein in N-Nitrosomorpholine (NNM) Treated Rats
- Published in:
- 2005
- By:
- Publication type:
- Abstract
Pretreatment peripheral neutrophils, lymphocytes and monocytes predict long-term survival in hepatocellular carcinoma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Self-rechargeable cardiac pacemaker system with triboelectric nanogenerators.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-24417-w
- By:
- Publication type:
- Article
Oncolytic and Immunotherapeutic Vaccinia Induces Antibody-Mediated Complement-Dependent Cancer Cell Lysis in Humans.
- Published in:
- Science Translational Medicine, 2013, v. 5, n. 185, p. 1, doi. 10.1126/scitranslmed.3005361
- By:
- Publication type:
- Article
Rational strain selection and engineering creates a broad-spectrum, systemically effective oncolytic poxvirus, JX-963.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Expression of Double-stranded RNA-activated Protein kinase (PKR) and its Prognostic Significance in Lymph Node Negative Rectal Cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2005, v. 35, n. 9, p. 545, doi. 10.1093/jjco/hyi146
- By:
- Publication type:
- Article
Comparative efficacy and safety of pharmacological interventions for the treatment of COVID-19: A systematic review and network meta-analysis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Immunotherapy for Peritoneal Carcinomatosis: Challenges and Prospective Outcomes.
- Published in:
- Cancers, 2023, v. 15, n. 8, p. 2383, doi. 10.3390/cancers15082383
- By:
- Publication type:
- Article
Engineering and Characterization of Oncolytic Vaccinia Virus Expressing Truncated Herpes Simplex Virus Thymidine Kinase.
- Published in:
- Cancers, 2020, v. 12, n. 1, p. 228, doi. 10.3390/cancers12010228
- By:
- Publication type:
- Article
Engineering and Preclinical Evaluation of Western Reserve Oncolytic Vaccinia Virus Expressing A167Y Mutant Herpes Simplex Virus Thymidine Kinase.
- Published in:
- Biomedicines, 2020, v. 8, n. 10, p. 426, doi. 10.3390/biomedicines8100426
- By:
- Publication type:
- Article
Association of 5α-Reductase Inhibitor Prescription With Bladder Cancer Progression in Males in South Korea.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 5, p. e2313667, doi. 10.1001/jamanetworkopen.2023.13667
- By:
- Publication type:
- Article